In recent trading session, AEON Biopharma Inc (AMEX:AEON) saw 0.65 million shares changing hands at last check today with its beta currently measuring 0.05. Company’s recent per share price level of $0.12 trading at $0.0 or -0.67% at last check today assigns it a market valuation of $9.54M. That most recent trading price of AEON’s stock is at a discount of -14208.33% from its 52-week high price of $17.17 and is indicating a premium of 16.67% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 76.81 million shares which gives us an average trading volume of 16.10 million if we extend that period to 3-months.
For AEON Biopharma Inc (AEON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.18 in the current quarter.
AEON Biopharma Inc (AMEX:AEON) trade information
Upright in the red during last session for losing -0.67%, in the last five days AEON remained trading in the red while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $0.12 price level, adding 21.62% to its value on the day. AEON Biopharma Inc’s shares saw a change of -77.93% in year-to-date performance and have moved -6.88% in past 5-day. AEON Biopharma Inc (AMEX:AEON) showed a performance of -79.80% in past 30-days. Number of shares sold short was 0.16 million shares which calculate 1.6 days to cover the short interests.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
Insiders are in possession of 36.23% of company’s total shares while institution are holding 33.14 percent of that, with stock having share float percentage of 51.98%. Investors also watch the number of corporate investors in a company very closely, which is 33.14% institutions for AEON Biopharma Inc that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 414.9 shares of worth $49373.0 or 0.52% of the total outstanding shares. The later fund manager was in possession of 320.9 shares on Sep 30, 2024, making its stake of worth around $38186.0 in the company or a holder of 0.40% of company’s stock.
